The Current Status of Type 2 Diabetes Management at a University Hospital.
10.4093/kdj.2009.33.3.241
- Author:
Young Sil LEE
1
Author Information
1. Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju, Korea. ysbae28@medimail.co.kr
- Publication Type:Original Article
- Keywords:
Disease management;
Treatment outcome;
Type 2 diabetes mellitus
- MeSH:
Blood Pressure;
Blood Pressure Monitors;
Body Mass Index;
Cardiovascular Diseases;
Diabetes Mellitus, Type 2;
Disease Management;
Humans;
Incidence;
Medical Records;
Platelet Aggregation Inhibitors;
Prevalence;
Treatment Outcome
- From:Korean Diabetes Journal
2009;33(3):241-250
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The prevalence of type 2 diabetes has increased worldwide, as have the incidence and mortality of associated cardiovascular complication. However current status of diabetes management is poor. This study was performed to evaluate the management of care for type 2 diabetes patients at a university hospital. METHODS: This study comprised 926 type 2 diabetes patients, over the age of 30, who were treated at the Dongguk University Gyeongju Hospital between January and December 2008. Medical records were reviewed to collect demographic information, biochemical test results and the pharmacologic agents prescribed. RESULTS: The mean age, duration of diabetes and body mass index were 62.5 +/- 11.8 years, 9.1 +/- 7.2 year and 24.7 +/- 6.3 kg/m2, respectively. There were 251/926 (27.1%) patients with cardiovascular disease. In addition, 49.2% and 27.5% of patients had HbA1c levels < 7% and < 6.5%, respectively. There were 66.3% of the patients with blood pressure < 130/80 mm Hg. Fifty one percent and 47.4% of the patients had an LDL-C < 100 mg/dL and a non-HDL-C < 130 mg/dL, respectively. In addition, 19.7% of the patients with cardiovascular disease had an LDL-C < 70 mg/dL. Antiplatelet agents were used in 81.2% of the patients. The mean number of HbA1c measurements was 1.07 +/- 0.7 /year. HbA1c and lipid profiles were not checked in 21.4% and 23.1% of the patients, respectively. Over the previous six months, 6.9% of the patients had not had their blood pressure monitored. CONCLUSION: Among the patients with type 2 diabetes evaluated, 30~70% received in inadequate level of care. These findings point to the need for more aggressive efforts for optimal metabolic control.
